共 50 条
- [7] Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04):
- [10] Natalizumab for relapsing remitting multiple sclerosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):